Obesity-Associated Cancers: Evidence from Studies in Mouse Models

Area of Science:

• Biomedical Science
• Oncology
• Metabolic Research

Background:

• Obesity is a global health issue linked to type 2 diabetes mellitus (T2DM) and at least 13 distinct cancers.
• Potential mechanisms include IGF pathway hyperactivation, metabolic dysregulation, angiogenesis dysfunction, and chronic inflammation.
• The precise mechanisms by which obesity drives diverse cancer types require further investigation.

Purpose of the Study:

• To investigate the intricate relationship between obesity and cancer development.
• To explore the biological pathways linking obesity to various malignancies.
• To leverage preclinical models for understanding obesity-cancer connections.

Main Methods:

• Utilized monogenic obesity mouse models (e.g., ob/ob, db/db mice).
• Employed genetically modified mouse models for human cancers (e.g., Kras-driven pancreatic, Apc-mutated colorectal, Her2/neu-overexpressing breast).
• Analyzed experimental data from these preclinical models.

Main Results:

• Preclinical mouse models provided strong evidence for a significant link between obesity and cancer.
• Identified key biological mechanisms potentially mediating the obesity-cancer association.
• Highlighted the utility of mouse models in cancer research.

Conclusions:

• Obesity is a significant risk factor for multiple cancer types.
• Understanding the underlying mechanisms is crucial for developing targeted interventions.
• Mouse models are valuable tools for dissecting the complex interplay between obesity and cancer.